ExpreS2ion Biotech

Read the full article at biostock.se:

https://www.biostock.se/2023/03/multiple-near-term-milestones-for-expres2ion-biotech/

This is a press release from BioStock - Connecting Innovation & Capital. https://www.biostock.se

The invitation to persons concerned to subscribe for units in ExpreS2ion Biotechnologies will only take place through the prospectus published on 27 March 2023. The prospectus has been approved and registered by the Financial Supervisory Authority and published on https://expres2ionbio.com/.